The future of immunopsychiatry: Three milestones to clinical innovation
Psychoneuroimmunology, the area of research dedicated to understanding the fundamental interactions between the central nervous system and the immune system, has given rise to the development of Immunopsychiatry, a new discipline which harnesses the immune system to produce beneficial outcomes for m...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-10-01
|
Series: | Brain, Behavior, & Immunity - Health |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666354621001174 |
_version_ | 1818363756678217728 |
---|---|
author | L.J. De Picker, MD PhD |
author_facet | L.J. De Picker, MD PhD |
author_sort | L.J. De Picker, MD PhD |
collection | DOAJ |
description | Psychoneuroimmunology, the area of research dedicated to understanding the fundamental interactions between the central nervous system and the immune system, has given rise to the development of Immunopsychiatry, a new discipline which harnesses the immune system to produce beneficial outcomes for mental health problems. Immunopsychiatry has the potential to become a clinically relevant specialty area in psychiatric practice, but has not yet been adopted by the wider mental health community. This paper aims to map out the future trajectory of Immunopsychiatry on its road towards science-to-policy knowledge translation and clinical implementation. Three critical milestones which will need to be reached in order for Immunopsychiatry to fulfil its promise for clinical innovation are discussed: a clear definition of patients who fall within the immunopsychiatric continuum; demonstration of well-defined clinical benefit and incorporation in clinical guidelines; and convergence with other paradigms in biological psychiatry. |
first_indexed | 2024-12-13T21:53:32Z |
format | Article |
id | doaj.art-c0eea101f00b41ccabdd75fe92204279 |
institution | Directory Open Access Journal |
issn | 2666-3546 |
language | English |
last_indexed | 2024-12-13T21:53:32Z |
publishDate | 2021-10-01 |
publisher | Elsevier |
record_format | Article |
series | Brain, Behavior, & Immunity - Health |
spelling | doaj.art-c0eea101f00b41ccabdd75fe922042792022-12-21T23:30:12ZengElsevierBrain, Behavior, & Immunity - Health2666-35462021-10-0116100314The future of immunopsychiatry: Three milestones to clinical innovationL.J. De Picker, MD PhD0University Psychiatric Hospital Campus Duffel, Duffel, Belgium; Collaborative Antwerp Psychiatric Research Institute, University of Antwerp, Antwerp, Belgium; University Psychiatric Hospital Campus Duffel, Duffel, Belgium.Psychoneuroimmunology, the area of research dedicated to understanding the fundamental interactions between the central nervous system and the immune system, has given rise to the development of Immunopsychiatry, a new discipline which harnesses the immune system to produce beneficial outcomes for mental health problems. Immunopsychiatry has the potential to become a clinically relevant specialty area in psychiatric practice, but has not yet been adopted by the wider mental health community. This paper aims to map out the future trajectory of Immunopsychiatry on its road towards science-to-policy knowledge translation and clinical implementation. Three critical milestones which will need to be reached in order for Immunopsychiatry to fulfil its promise for clinical innovation are discussed: a clear definition of patients who fall within the immunopsychiatric continuum; demonstration of well-defined clinical benefit and incorporation in clinical guidelines; and convergence with other paradigms in biological psychiatry.http://www.sciencedirect.com/science/article/pii/S2666354621001174ImmunopsychiatryPsychoneuroimmunologyTranslationalPolicyPsychiatryInnovation |
spellingShingle | L.J. De Picker, MD PhD The future of immunopsychiatry: Three milestones to clinical innovation Brain, Behavior, & Immunity - Health Immunopsychiatry Psychoneuroimmunology Translational Policy Psychiatry Innovation |
title | The future of immunopsychiatry: Three milestones to clinical innovation |
title_full | The future of immunopsychiatry: Three milestones to clinical innovation |
title_fullStr | The future of immunopsychiatry: Three milestones to clinical innovation |
title_full_unstemmed | The future of immunopsychiatry: Three milestones to clinical innovation |
title_short | The future of immunopsychiatry: Three milestones to clinical innovation |
title_sort | future of immunopsychiatry three milestones to clinical innovation |
topic | Immunopsychiatry Psychoneuroimmunology Translational Policy Psychiatry Innovation |
url | http://www.sciencedirect.com/science/article/pii/S2666354621001174 |
work_keys_str_mv | AT ljdepickermdphd thefutureofimmunopsychiatrythreemilestonestoclinicalinnovation AT ljdepickermdphd futureofimmunopsychiatrythreemilestonestoclinicalinnovation |